Products
Lidoderm®
Versatis®
Non-Alcohol Docetaxel Injection
Pipeline
TPU-006
TPU-010
TK-254R
Technology
Hydrohesive
Matrix
Company
Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press
News
Products
Lidoderm®
Versatis®
Non-Alcohol Docetaxel Injection
Pipeline
TPU-006
TPU-010
TK-254R
Technology
Hydrohesive
Matrix
Company
Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press
News
Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management
Company
Parent Company
Management
Scientific Advisory Board
Partnerships
Affiliates
Careers
News & Press
June 21, 2023
Jess Borges
Teikoku Pharma granted FDA Fast Track Designation for TPU-006, a Novel 4-day Dexmedetomidine Transdermal System for Post Operative Pain Management